Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life.
Westhofen T, Buchner A, Lennartz S, Rodler S, Eismann L, Aydogdu C, Askari-Motlagh D, Berg E, Feyerabend E, Kazmierczak P, Jokisch F, Becker A, Stief CG, Kretschmer A.
Westhofen T, et al. Among authors: stief cg.
World J Urol. 2024 Oct 20;42(1):585. doi: 10.1007/s00345-024-05298-2.
World J Urol. 2024.
PMID: 39427278
Free PMC article.